| IVGSX | VIVAX | IVGSX / VIVAX | |
| Total Expense Ratio | 0.89 | 0.17 | 524% |
| Annual Report Gross Expense Ratio | 0.89 | 0.17 | 524% |
| Fund Existence | 32 years | 33 years | - |
| Gain YTD | -4.750 | 14.025 | -34% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 3000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 163M | 216B | 0% |
| Annual Yield % from dividends | 2.60 | 1.93 | 135% |
| Returns for 1 year | -6.00 | 12.66 | -47% |
| Returns for 3 years | 3.88 | 37.81 | 10% |
| Returns for 5 years | 9.38 | 64.99 | 14% |
| Returns for 10 years | -3.00 | 134.86 | -2% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| LAFTX | 20.45 | 0.07 | +0.34% |
| Lord Abbett Affiliated R5 | |||
| AEMMX | 14.21 | 0.03 | +0.21% |
| American Century Emerging Markets A | |||
| NAINX | 9.77 | 0.02 | +0.21% |
| Virtus Tactical Allocation A | |||
| BKDEX | 10.80 | 0.01 | +0.09% |
| BlackRock Defensive Advantage EM K | |||
| BIPSX | 36.16 | N/A | N/A |
| ProFunds Biotechnology UltraSector Svc | |||